“Seon A Jo”에 대한 검색 결과 – 페이지 5

Evaluation of the Vitek 2 Korean Antimicrobial Susceptibility Testing Cards AST N056 and AST N055

Original article PDF So Youn Shin, Sun Hoe Koo, Kye Chul Kwon, Jong Woo Park, Chi Seon Ko, Jung Hoon Song, Ji Youn Sung Department of Laboratory Medicine, Chungnam National University Hospital, Daejeon, Korea Corresponding to Kye Chul Kwon, E-mail: kckwon@cnu.ac.kr Ann Clin Microbiol 2008;11(1):23-28.Copyright © Korean Society of Clinical Microbiology. Abstract Background: The recently issued Korean version of antimicrobial susceptibility cards for Vitek 2 system uses an adjusted antimicrobial combination that reflects Korean clinical practice and CLSI guidelines. We evaluated the two Korean antimicrobial susceptibility testing cards for gram negative rods, AST N056 and AST N055. Methods: The results of susceptibility tests were compared between the original and Korean cards. A number of the same antimicrobials included in the both cards were 15 in AST N041-AST N056 and 17 in AST N022-AST N055. Susceptibilities to the newly added antimicrobials, aztreonam, tobramycin, and meropenem for AST N056; and cefotaxime, levofloxacin,

Detection of the Causative Agents of Traveler’s Diarrhea Using a Real-Time PCR Screening Method

Original article PDF Semi Jeon1, Junyoung Kim1, Harim Lee2, Minyoung Son2, Misun Park1, Bokkwon Lee1, Seonghan Kim1 1Division of Enteric Bacterial Infections, National Institute of Health, Seoul, 2Gimhae National Quarantine Station, Gimhae, Korea Corresponding to Seonghan Kim, E-mail: kkingsh@chol.com Ann Clin Microbiol 2009;12(4):186-192.Copyright © Korean Society of Clinical Microbiology. Abstract Background: The incidence of infectious diarrheal disease in Korea has decreased over the past decade, but traveler’s diarrhea (TD) is increasing in frequency. We therefore investigated the distribution of the causative agents of TD. Methods: A total of 132 rectal swab specimens were acquired from TD patients who entered the country via Gimhae International Airport. The specimens were screened for 12 bacterial pathogens by real-time PCR, and target pathogens were isolated from the PCR positive specimens using conventional microbiological isolation methods. Results: A total of 93 specimens (70.5%) showed positive PCR screening results, and of these specimens, nine species and 50

Perineal Colonization Rate and Antimicrobial Susceptibility of Group B Streptococcus in Pregnant and Non-Pregnant Korean Women

Original article PDF Sun-Hwa Lee1, Kyoung Un Park2, Hae-Kyung Lee3, Mi Young Kim1, Jin Yong Kim1, Won Kyoung Kwon1, Lee Sun Park1 Department of Laboratory Medicine, 1Neodin Medical Institute, Seoul, 2Seoul National University Bundang Hospital, Seongnam, 3The Catholic University of Korea College of Medicine, Seoul, Korea Corresponding to Sun-Hwa Lee, E-mail: lshkim@neodin.com Ann Clin Microbiol 2009;12(4):180-185.Copyright © Korean Society of Clinical Microbiology. Abstract Background: Group B Streptococcus (Streptococcus agalactiae, GBS) is a major cause of severe infections in neonates, including bacteremia, pneumonia, and meningitis, and is generally vertically transmitted from a colonized, pregnant woman to her infant. Penicillin is the drug of choice to treat GBS infections, because GBS strains are uniformly susceptible to penicillin. Recently, however, penicillin resistant GBS strains have been reported and the rates of erythromycin and clindamycin resistance have increased. We evaluated the perineal colonization rates and antimicrobial susceptibility of GBS strains isolated from pregnant and non-pregnant women. Methods: The antibiotic

SARS-CoV2 mutation detection experience using PowerChek SARS-CoV-2 S-gene Mutation Detection Kit

Letter to the editor Sun-Mi Cho, Yeon Hee Choi, Seong Geun Hong, Myung Seo Kang Department of Laboratory Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea Corresponding to Myung Seo Kang, E-mail: olive@chamc.co.kr; Seong Geun Hong, E-mail: hlseo@cha.ac.kr Ann Clin Microbiol 2023;26(3):83-86. https://doi.org/10.5145/ACM.2023.26.3.6Received on 7 March 2023, Revised on 19 July 2023, Accepted on 13 August 2023, Published on 20 September 2023.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. 2019년 12월 코로나바이러스감염증-19 (COVID-19)의 원인 바이러스인 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)가 검출된 이후 다양한 유전적 변이가 보고되었다[1]. SARSCoV-2 변이의 수가 증가함에 따라, 백신 접종 시 면역력 저하와 함께 감염성 증가 및 임상적 중증도 측면에서 위협이 되고 있다[2–4]. 세계보건기구에서 세계 보건에 상당한 위험을 초래하는 변이

Risk factor analysis of urinary tract infection by cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae: a simple and effective analysis using the National Health Insurance Data Sharing Service

Original article Jae Kwang Lee1, Yoonseon Park2, Young Ah Kim3 1Department of Research and Analysis, National Health Insurance Service Ilsan Hospital, Goyang, 2Division of Infectious Diseases Department of Internal Medicine Gil Medical Center, Gachon University College of Medicine, Incheon, 3Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea Corresponding to Young Ah Kim, E-mail: yakim@nhimc.or.kr; Yoonseon Park, E-mail: yoonseony@gilhospital.com Ann Clin Microbiol 2023;26(3):59-66. https://doi.org/10.5145/ACM.2023.26.3.3Received on 24 April 2023, Revised on 17 August 2023, Accepted on 30 August 2023, Published on 20 September 2023.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: This study aims to analyze the risk factors for urinary tract infection (UTI) by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae, using

Epidemiology and subtype distribution of Blastocystis among asymptomatic volunteers in Korea: a multicenter study

Original article Seong Hoon Kim1,2*, Jung-Hyun Byun3*, YeJin Oh4, Changseung Liu5, Mi Hyun Bae6, Eun Jeong Won1,2,7 1Department of Parasitology and Tropical Medicine, Chonnam National University Medical School, Hwasun, 2Department of Biomedical Sciences, Graduate School of Chonnam National University, Hwasun, 3Department of Laboratory Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, 4Department of Laboratory Medicine, Green Cross Laboratories (GC Labs), Yongin, 5Department of Laboratory Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, 6Department of Laboratory Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, 7Department of Laboratory Medicine, Asan Medical Center, Seoul, Korea *These authors contributed equally to this work. Corresponding to Eun Jeong Won, E-mail: dana_clinic@naver.com Ann Clin Microbiol 2023;26(1):11-17. https://doi.org/10.5145/ACM.2023.26.1.2Received on 27 January 2023, Revised on 27 February 2023, Accepted on 3 March 2023, Published on 20 March 2023.Copyright © Korean Society of Clinical Microbiology.This is an Open Access

Syndromic testing for sexually transmitted infection: current and future demand

Review article In Young Yoo Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Corresponding to In Young Yoo, E-mail: yiy00@naver.com Ann Clin Microbiol 2023;26(1):1-9. https://doi.org/10.5145/ACM.2023.26.1.1Received on 9 January 2023, Revised on 27 February 2023, Accepted on 27 February 2023, Published on 20 March 2023.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Sexually transmitted infections (STIs) are a major global public health problem, with significant social burden worldwide. Accurate and appropriate diagnosis and treatment of STIs are important for preventing the transmission of STIs as well as major health consequences of untreated STIs, such as infertility and certain cancer. For diagnosis of STIs, the application of

Antimicrobial resistance patterns of Acinetobacter baumannii and Pseudomonas aeruginosa isolated from vulnerable patients in Korea, 2021

Original article Young Ah Kim1, Seok Hoon Jeong2,3, Jong Hee Shin4, Kyeong Seob Shin5, Jeong Hwan Shin6, Young Ree Kim7, Hyun Soo Kim8, Young Uh9, Nam Hee Ryoo10 1Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, 2 Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, 3Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, 4Department of Laboratory Medicine, Chonnam National University Medical School, Gwangju, 5Department of Laboratory Medicine, Chungbuk National University College of Medicine, Cheongju, 6Department of Laboratory Medicine and Paik Institute for Clinical Research, Inje University College of Medicine, Busan, 7Department of Laboratory Medicine, Jeju National University College of Medicine, Jeju, 8Department of Laboratory Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, 9Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, 10Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea Corresponding to Young

Antibody detection in healthcare workers after vaccination with two doses of the BNT162b2 or ChAdOx1 vaccine

Original article Kyoung Ho Roh1, Heun Choi2, HeeKyoung Choi2, Miseon Yoon3, Jongha Yoo1, Yoonseon Park4 Department of 1Laboratory Medicine, 2Infectious Diseases, 3Infection Control Center, National Health Insurance Service Ilsan Hospital, Goyang, 4Division of Infectious Diseases, Department of Internal Medicine Gil Medical Center, Gachon University College of Medicine, Incheon, Korea Corresponding to Yoonseon Park, E-mail: yoonseony@gmail.com Ann Clin Microbiol 2022;25(3):85-95. https://doi.org/10.5145/ACM.2022.25.3.4Received on 24 August 2022, Revised on 13 September 2022, Accepted on 13 September 2022, Published on 20 September 2022.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Due to the COVID-19 pandemic, from 2020, many pharmaceutical companies have developed vaccines. To determine the efficacy of AstraZeneca’s and Pfizer’s vaccines, which were the first and second

On-field evaluation of exdia COVID-19 antigen point-of-care testing in the emergency department during the COVID-19 pandemic

Original article In Young Yoo1, Gun Dong Lee1, Hyojin Chae1, Chun Song Youn2, Eun-Jee Oh1, Yeon-Joon Park1 Department of 1Laboratory Medicine, 2Emergency Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Corresponding to Yeon-Joon Park, E-mail: yjpk@catholic.ac.kr Ann Clin Microbiol 2022;25(3):73-78. https://doi.org/10.5145/ACM.2022.25.3.2Received on 25 January 2022, Revised on 1 May 2022, Accepted on 17 May 2022, Published on 20 September 2022.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: We evaluated the diagnostic performance of the Exdia COVID-19 antigen test (Exdia Ag; Precision Biosensor Inc., Korea) as a point-of-care (POC) test performed in the emergency department (ED) for the rapid detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in

Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology

6

Weeks in Review

4

Weeks to Publication

Indexed in KCI, KoreaMed, Synapse, DOAJ

Open Access, Peer Reviewed

pISSN 2288-0585 eISSN 2288-6850

6